Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Rev. chil. infectol ; 28(5): 470-473, oct. 2011. ilus, tab
Article in Spanish | LILACS | ID: lil-603086

ABSTRACT

Pathogenic Vibrio cholerae isolates, the etiologic agents of cholera, generally express one of two O antigens (O1 or O139). Most environmental isolates are nonpathogenic and are referred to as "non-O1, non-O139". However some V. cholerae non-O1, non-O139 strains are clearly pathogenic and have caused outbreaks or sporadic cases of gastroenteritis and extraintestinal infections in humans. We report a case of acute gastroenteritis by a V. cholerae non-O1, non-O139 harboring a genetic region homologous to a segment of the VpaI-7 V. parahaemolyticus pathogenicity island.


Cepas patogénicas de Vibrio cholerae, el agente causal del cólera, expresan generalmente uno de dos antígenos O (denominados O1 u O139). La mayoría de las cepas ambientales son no patogénicas y corresponden al tipo denominado "no-O1, no-O139". Sin embargo, algunas cepas de este tipo son claramente patogénas y han causado brotes de gastroenteritis e infecciones extra-intestinales en humanos. Se reporta un caso clínico de gastroenteritis aguda causado por una cepa de V. cholerae no-O1, no-O139 que contiene en su genoma una región homóloga a un segmento de la isla de patogenicidad VpaI-7 descrita previamente en V. parahaemolyticus.


Subject(s)
Female , Humans , Middle Aged , Gastroenteritis/microbiology , Genomic Islands/genetics , Vibrio Infections/microbiology , Vibrio cholerae/genetics , Acute Disease , Anti-Infective Agents/therapeutic use , Ciprofloxacin/therapeutic use , Gastroenteritis/diagnosis , Gastroenteritis/drug therapy , Vibrio Infections/diagnosis , Vibrio Infections/drug therapy , Vibrio cholerae non-O1/genetics
2.
Rev. argent. microbiol ; 43(2): 81-83, jun. 2011.
Article in Spanish | LILACS | ID: lil-634675

ABSTRACT

Vibrio cholerae no-O1, no-O139 es un agente poco frecuente como causal de bacteriemias y no hay informes que documenten su presencia en pacientes en hemodiálisis crónica. Se describe el caso de una paciente en hemodiálisis crónica que presentó un cuadro de sepsis, por lo cual inició un tratamiento con vancomicina y ceftacidima. Al cabo de seis horas y media de incubación en el sistema BACT/ALERT de hemocultivo, se evidenció la presencia de bacilos curvos gram negativos, posteriormente identificados como Vibrio cholerae mediante pruebas bioquímicas convencionales y el uso de los kits API 20 NE y VITEK 2. La evaluación del serogrupo y de la presencia de factores de patogenicidad, realizada en el laboratorio de referencia, determinó que el microorganismo hallado pertenecía al serogrupo no-O1, no-O139. No se detectó la toxina de cólera, tampoco el factor de colonización ni la toxina termoestable. El aislamiento presentó sensibilidad frente a ampicilina, trimetoprima-sulfametoxazol, ciprofloxacina, tetraciclina, ceftacidima y cefotaxima por el método de difusión con discos y por VITEK 2. La paciente cumplió 14 días de tratamiento con ceftacidima endovenosa, con evolución favorable.


Non-O1, and non-O139 Vibrio cholerae is an infrequent cause of bacteremia. There are no reports of such bacteremia in chronic hemodialysis patients. This work describes the case of a chronic hemodialysis patient that had an episode of septicemia associated with dialysis. Blood cultures were obtained and treatment was begun with vancomycin and ceftazidime. After 6.5 hours of incubation in the Bact/Alert system there is evidence of gram-negative curved bacilli that were identified as Vibrio cholerae by conventional biochemical tests, API 20 NE and the VITEK 2 system. This microorganism was sent to the reference laboratory for evaluation of serogroup and virulence factors and was identified as belonging to the non-O1 and non-O139 serogroup. The cholera toxin, colonization factor and heat-stable toxin were not detected. The isolate was susceptible to ampicillin, trimethoprim-sulfamethoxazole, ciprofloxacin, tetracycline, ceftazidime and cefotaxime by the disk diffusion method and the VITEK 2 system. The patient received intravenous ceftazidime for a 14 day- period and had a favorable outcome.


Subject(s)
Aged, 80 and over , Female , Humans , Bacteremia/microbiology , Kidney Failure, Chronic/complications , Renal Dialysis , Vibrio Infections/microbiology , Vibrio cholerae non-O1/isolation & purification , Anti-Bacterial Agents/pharmacology , Bacteremia/complications , Bacteremia/drug therapy , Bacterial Typing Techniques/methods , Ceftazidime/administration & dosage , Ceftazidime/therapeutic use , Drug Resistance, Multiple, Bacterial , Diabetic Nephropathies/complications , Diabetic Nephropathies/therapy , Immunocompromised Host , Kidney Failure, Chronic/therapy , Microbial Sensitivity Tests , Risk Factors , Virulence , Vancomycin/administration & dosage , Vancomycin/therapeutic use , Vibrio Infections/complications , Vibrio Infections/drug therapy , Vibrio cholerae non-O1/drug effects , Vibrio cholerae non-O1/pathogenicity
3.
The Korean Journal of Gastroenterology ; : 350-352, 2011.
Article in Korean | WPRIM | ID: wpr-8178

ABSTRACT

Vibrio cholerae non-O1 have caused several well-studied food-borne outbreaks of gastroenteritis and also have been responsible for sporadic cases of otitis media, wound infection, and bacteremia. Few cases of liver abscess caused by Vibrio cholerae non-O1 have been reported. A 73-year-old man with underlying diabetes mellitus was admitted with nausea, vomiting, dyspepsia and febrile sensation. We identified Vibrio cholerae non-O1 in his blood cultures and multiple hepatic microabscess on abdominal computed tomography. He was treated with systemic antibiotics and fluid therapy, but died due to septic shock on sixth day. We report here, a case of liver abscess with bacteremia due to Vibrio cholerae non-O1 in a patient with diabetes mellitus.


Subject(s)
Aged , Humans , Male , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Ceftriaxone/therapeutic use , Liver Abscess/diagnosis , Metronidazole/therapeutic use , Shock, Septic/diagnosis , Tomography, X-Ray Computed , Vibrio Infections/drug therapy , Vibrio cholerae non-O1/isolation & purification
4.
Electron. j. biotechnol ; 13(1): 8-9, Jan. 2010. ilus, tab
Article in English | LILACS | ID: lil-559591

ABSTRACT

Pseudomonas sp. W3, a bacterium known to produce an extracellular alkaline protease, secreted secondary metabolites that inhibited pathogenic bacteria responsible for shrimp luminous vibriosis disease. Antivibrio compounds in the culture supernatant or culture filtrates (0.45 um and 0.22 um) of the isolate W3 were tested using an agar well diffusion method on a number of pathogenic vibrios. Vibrio harveyi PSU 2015 a pathogenic isolate was the most sensitive strain. The effectiveness of preparations from the isolate W3 against V. harveyi PSU 2015, and V. cholerae PSSCMI 0062 was in the order of culture supernatant > 0.45 um culture filtrate > 0.22 um culture filtrate. These extracellular antivibrio compounds also lysed both dead and living cells of V. harveyi PSU 2015. Results of the partial characterization tests indicated that there was some particulate antivibrio compound that was destroyed by treatment with enzymes particularly alpha-chymotrypsin, autoclaving at 121ºC for 15 min and was mostly removed by filtration through a 0.22 µm filter. Most of the inhibitory compounds were of small molecular weight able to pass through a 0.22 um filter and were resistant to treatment with various enzymes, pH values between 4-8 and temperatures up to 121ºC for 30 min. The optimum pH for the antivibrio activity in the 0.45 um culture filtrate was between pH 6-7.


Subject(s)
Animals , Decapoda , Decapoda , Decapoda/metabolism , Decapoda/microbiology , Pseudomonas , Pseudomonas/metabolism , Vibrio Infections/microbiology , Vibrio Infections/drug therapy , Chloramphenicol/therapeutic use , Furazolidone/therapeutic use , Culture Techniques/methods
5.
Rev. chil. infectol ; 26(4): 360-362, ago. 2009.
Article in Spanish | LILACS | ID: lil-527881

ABSTRACT

Vibrio parahaemolyticus is a facultative anaerobio gram negative rod responsible of sea food-associated diarr-hoea. Although less common, it also causes wound infections and bacteraemia. We present a case of bacteraemia by this agent and a review of the literature.


Vibrio parahaemolyticus es un bacilo gram negativo, anaerobio facultativo, responsable de brotes de síndrome diarreico agudo por ingestión de mariscos crudos o mal cocidos contaminados. Ocasionalmente. se ha reportado asociado a infección de heridas y sepsis. Se reporta un caso clínico de bacteriemia por este microorganismo y se realiza una revisión de la literatura.


Subject(s)
Aged, 80 and over , Humans , Male , Bacteremia/microbiology , Vibrio Infections/microbiology , Vibrio parahaemolyticus/isolation & purification , Anti-Infective Agents/therapeutic use , Bacteremia/diagnosis , Bacteremia/drug therapy , Ciprofloxacin/therapeutic use , Treatment Outcome , Vibrio Infections/diagnosis , Vibrio Infections/drug therapy
6.
Bol. Asoc. Méd. P. R ; 83(4): 154-6, abr. 1991.
Article in English | LILACS | ID: lil-107889

ABSTRACT

Los vibrios halofílicos son bacterías gram-negativas en forma de bacilos curvos que requieren altas concentraciones de sal para sobrevivir. Usualmente se encuentran en el medio ambiente marino a través del mundo. Las infeccioens causadas por estos organismos están usualmente asociados con la ingesta de marisco o la exposición de alguna herida a agua de mar. La presentación clínica y severidad de estas infecciones es muy variada. La presentación más común son síntomas no muy severos de gastroenteritis, pero puden ocurrir infecciones de tejido blando y septicemias presentando mortalidad elevada especialmente en pacientes con condiciones hepáticas pre-existentes. La detección temprana e inicio de tratamiento adequado con tetraciclina es de suma importancia debido a la rápida progresión de esta infección


Subject(s)
Vibrio Infections , Seawater , Vibrio Infections/diagnosis , Vibrio Infections/drug therapy , Vibrio Infections/epidemiology , Vibrio Infections/etiology , Vibrio Infections/prevention & control , Water Microbiology
SELECTION OF CITATIONS
SEARCH DETAIL